Company intelligence / Profile preview

CAS Star

Xi'an, Shaanxi, China

Ownership: Private
Development stage: Other

Overview

CAS Star is a leading Chinese venture capital firm, focused on early-stage investments in hard tech startups, especially in advanced technology sectors including biotech, medical devices, neuroscience, cell and gene therapy, AI, photonics, and energy; its portfolio companies have advanced to clinical and commercialization stages, particularly in medtech and biotechnology[1][2][5].

Industry: Investors

Partnerships

Investments/co-investments include collaborations with other VC firms (e.g., Yunqi Partners)

Beyond the preview

Go deeper on CAS Star.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CAS Star.

Explore the full profile